Risk of major adverse cardiovascular events with dolutegravir versus efavirenz-based antiretroviral therapy: emulated target trials using routine, de-identified data from South Africa
Dorward J., Masombuka X., Lewis L., Pastellides C., van der Molen J., Asare K., Tlhaku K., Brown JA., Bottomley C., Jacobs D., Collie S., Garrett N.